logo
#

Latest news with #NephroPlus

Dialysis chain NephroPlus engages with bankers for planned $200-250 mn IPO
Dialysis chain NephroPlus engages with bankers for planned $200-250 mn IPO

Mint

time22-05-2025

  • Business
  • Mint

Dialysis chain NephroPlus engages with bankers for planned $200-250 mn IPO

Mumbai: Dialysis chain NephroPlus has engaged with bankers for a planned initial public offering to raise $200-250 million to fund expansion, two people familiar with the matter told Mint. Backed by Investcorp and Quadria Capital, the company will file its draft papers with the regulator over the next three months, with the listing likely by next year, one person said. The person said the IPO will have a fresh capital raise and an offer by existing investors looking to sell a part of their stake. 'NephroPlus has engaged with ICICI Securities, IIFL Capital Services, Nomura and Ambit Capital to help with the issue," the second person said. NephroPlus and the investment banks did not respond to Mint's requests for comment on the proposed IPO. Also Read | Patients saved ₹16,000 crore under Centre's free dialysis scheme Quadria, a healthcare-focused private equity firm, invested about ₹850 crore for a minority stake in NephroPlus last year through a combination of a primary investment and the purchase of shares from Investcorp, Bessemer Venture Partners, IFC, and IIFL Private Equity. NephroPlus planned to use the funds raised from Quadria in the IPO for growth in India and overseas. With plans for additional acquisitions, specialised chains such as NephroPlus are expected to gain market share as hospitals increasingly outsource dialysis operations and governments seek to make high-quality dialysis services more accessible. Demand for dialysis services in the company's target markets is expected to grow at over 11% annually over the next five years, Quadria said when it invested in the company in May 2024. Founded by Vikram Vuppala and Kamal Shah in 2010, the Hyderabad-based company operates about 450 dialysis centres in 250+ towns and cities across India, the Philippines and Uzbekistan. It serves about 30,000 patients, carrying out 3 million dialysis sessions each year. Healthcare growth The company operates in marquee hospitals and standalone clinics, working with leading nephrologists, and also through public-private partnerships in urban and rural areas. Over the past three years, NephroPlus entered the Philippines by acquiring Royal Care Dialysis Centers Inc. and won a public-private partnership bid in Uzbekistan. NephroPlus' revenue grew to ₹566 crore in FY24 from ₹438 crore a year earlier. It recorded a profit of ₹35 crore from a loss of ₹12 crore in FY23, according to an Entrackr report. Also Read | Choppy markets take toll on pre-IPO deal talks The Indian healthcare ecosystem is expected to grow at a CAGR of 16% to $527 billion over the next five years from $250 billion in FY24. The market includes services such as healthcare delivery, diagnostics, medical devices, pharmaceuticals, financing, and health-tech, according to a report by Praxis Global Alliance last year. Of the $250 billion, healthcare delivery accounts for about 55% (about $135 billion) and is expected to grow at a CAGR of 18% over the next five years. Praxis added that the growth will be primarily driven by changing demographics, increasing urbanisation and health insurance coverage, improving medical tourism, favourable government policies, and rising health awareness and accessibility.

Don't Let Hypertension Ruin Your Kidneys; Keep your kidneys healthy
Don't Let Hypertension Ruin Your Kidneys; Keep your kidneys healthy

Time of India

time18-05-2025

  • Health
  • Time of India

Don't Let Hypertension Ruin Your Kidneys; Keep your kidneys healthy

Nearly 30% of Chronic Kidney disease in India is due to Hypertension (HIGH BLOOD PRESSURE) and for most patients with kidney disease, high blood pressure increases the risk of kidney disease worsening. Awareness of the impact and importance of high BP is poor. Most remain unaware of healthy lifestyle to prevent or control BP. In CKD (Chronic Kidney Disease), hypertension is responsible for the gradual loss of kidney function, which also increases the risk of stroke and heart attack. Improving BP control slows down progression of kidney. In addition healthy diet, increased physical activity will aid control of BP. Lack of symptoms gives a false sense of 'good health' which can be self-monitoring and healthier life style will pay rich dividends. Basics of hypertension and kidney health Kidneys and circulatory system are closely inter connected. Hypertension places strain on large and small arteries throughout the body. In the kidneys, blood vessels narrow, weaken, and harden. With this damage, the patient's kidney filter could get affected. This, in turn, results in kidney disease and also progression of kidney disease. Key interventions : • Medication: right dose. Frequency and titration • BP monitoring - frequently • Food low in fat and salt • Stop smoking and avoid consuming any type of tobacco products • Ensure you exercise regularly (talk to your health care provider before starting) Hypertension is common, easily detectable, controllable. Hypertension management prevents kidney disease, heart attacks, stroke and results in significant health promotion. (By Dr. Suresh Sankar, Nephrologist, Senior Vice President, Global Clinical Affairs, NephroPlus) One step to a healthier you—join Times Health+ Yoga and feel the change

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store